Darbepoetin alfa 10mcg/0.4mL, 25mcg/0.42mL, 40mcg/0.4mL, 60mcg/0.3mL, 100mcg/0.5mL, 150mcg/0.3mL, 200mcg/0.4mL, 300mcg/0.6mL, 500mcg/mL; per prefilled syringe; for IV ...

Drugs/Procedures Used: Patients were randomized in a 1:1 fashion to receive either darbepoetin alfa or placebo, supplied in matching syringes at 12 different strengths. Concomitant Medications ...

According to the results of a single-center, prospective, crossover study, darbepoetin alfa—a hyperglycosylated, and therefore longer-acting, derivative of epoetin—is a more effective ...

Patients were randomized to receive monthly injections of either darbepoetin or placebo; treatment was withheld when hemoglobin levels exceeded 13 g/dL. During the 17-week study, hemoglobin levels ...